We were shut down by COVID patient enrollment restrictions, while in Phase I and are re-initiating that with the US FDA. We have already had 3 meetings with them and they agreed we could go forward after they reviewed translations from our Chinese Jt. Venture partner which conducted the research. We are in the process of doing that. If that is not acceptable then we will test on nude mice here in Houston. Everything is formulated here in Texas and Marvax™ will be manufactured here and sent out World Wide.
Marvax™ Utilizing the Human Body in Defeating Cancer and Disease Through Cost Effective Immunogens. Shrinking cancerous tumors in 11 major cancers.
Our management team has over 40 years of investing and managing public and private companies involved in cancer research and development which has lead to approval by the FDA. As CEO our chairman has developed and managed a Fortune 500 Company.
I am enclosing our offering documents for our reverse merger common stock offering of $10 Million We are also raising $25 Million in our second 41-C limited partnership offering. They only allow 10mb. The IRS under 41-C pays for your investment in that partnership is you have paid taxes on passive income and gives you a further 20% credit.
Peter P. Smetek, Jr.
Chairman CEO
Gordian Holdings, Inc.
281-777-5489
Ready to Ask For Funding for your company?
Post a Funding Request